IRF6 anticorps (C-Term)
Aperçu rapide pour IRF6 anticorps (C-Term) (ABIN630193)
Antigène
Voir toutes IRF6 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- IRF6 antibody was raised against the C terminal of IRF6
-
Purification
- Purified
-
Immunogène
- IRF6 antibody was raised using the C terminal of IRF6 corresponding to a region with amino acids FLSDLIAHQKGQIEKQPPFEIYLCFGEEWPDGKPLERKLILVQVIPVVAR
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
IRF6 Blocking Peptide, (ABIN938372), is also available for use as a blocking control in assays to test for specificity of this IRF6 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IRF6 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- IRF6 (Interferon Regulatory Factor 6 (IRF6))
-
Autre désignation
- IRF6
-
Sujet
- IRF6 is a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. Mutations in its gene can cause van der Woude syndrome and popliteal pterygium syndrome. This protein is involved in palate formation.
-
Poids moléculaire
- 65 kDa (MW of target protein)
Antigène
-